Advanced Biomed (ADVB) Annual Balance Sheets

Annual · GAAP · USD millions
Access ADVB quarterly Balance Sheets →
From Advanced Biomed through , shifts in Jun 30 2024's assets and liabilities provide insight into the company's capital structure and financial stability.
Annual Report, GAAP in USD millions
ITEM
(Jun 30 2024)
Assets
Cash & cash equivalent2.61
Cash & Short-term Investments2.00
Total loans net0.24
Total Current Assets3.05
Equipment/Property/Plant Net1.76
Intangible Assets0.12
Tax Assets, Noncurrent2.02
Deferred, Prepaid and Other Assets, Noncurrent0.64
Total Assets4.46
Liabilities
Accounts Payable2.67
Accrued Liabilities, Current0.08
Short-term Debt1.59
Total Current Liabilities2.73
Total Long-term Debt0.00
Total Liabilities2.80
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock16.49
Retained Earnings / Accumulated Deficit-15.97
Accumulated Other Comprehensive Income1.12
Other Equity1.12
Common Stockholder's Equity1.66
Total Stockholder's Equity1.66
Liabilities & Stockholder's Equity4.46
4 historic quarters locked

Sign in to unlock the full Advanced Biomed balance sheet history.

About Advanced Biomed Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-25-097465

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.